Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

The Conventional Nature of Non-MHC-Restricted T Cells.

Lepore M, Mori L, De Libero G.

Front Immunol. 2018 Jun 14;9:1365. doi: 10.3389/fimmu.2018.01365. eCollection 2018. Review.

2.

Editorial overview: Antigen processing.

De Libero G.

Curr Opin Immunol. 2018 Jun;52:iv-v. doi: 10.1016/j.coi.2018.05.016. No abstract available.

PMID:
29907238
3.

Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation.

Schmaler M, Colone A, Spagnuolo J, Zimmermann M, Lepore M, Kalinichenko A, Bhatia S, Cottier F, Rutishauser T, Pavelka N, Egli A, Azzali E, Pieroni M, Costantino G, Hruz P, Sauer U, Mori L, De Libero G.

Mucosal Immunol. 2018 Jul;11(4):1060-1070. doi: 10.1038/s41385-018-0020-9. Epub 2018 May 9.

PMID:
29743612
4.

NLRP10 Enhances CD4+ T-Cell-Mediated IFNγ Response via Regulation of Dendritic Cell-Derived IL-12 Release.

Vacca M, Böhme J, Zambetti LP, Khameneh HJ, Paleja BS, Laudisi F, Ho AWS, Neo K, Leong KWK, Marzuki M, Lee B, Poidinger M, Santambrogio L, Tsenova L, Zolezzi F, De Libero G, Singhal A, Mortellaro A.

Front Immunol. 2017 Nov 2;8:1462. doi: 10.3389/fimmu.2017.01462. eCollection 2017.

5.

Correction: Functionally diverse human T cells recognize non-microbial antigens presented by MR1.

Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, Narang V, Zolezzi F, Poidinger M, Mori L, De Libero G.

Elife. 2017 Jun 20;6. pii: e29743. doi: 10.7554/eLife.29743. No abstract available.

6.

Functionally diverse human T cells recognize non-microbial antigens presented by MR1.

Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, Narang V, Zolezzi F, Poidinger M, Mori L, De Libero G.

Elife. 2017 May 18;6. pii: e24476. doi: 10.7554/eLife.24476. Erratum in: Elife. 2017 Jun 20;6:.

7.

Contact sensitizers trigger human CD1-autoreactive T-cell responses.

Betts RJ, Perkovic A, Mahapatra S, Del Bufalo A, Camara K, Howell AR, Martinozzi Teissier S, De Libero G, Mori L.

Eur J Immunol. 2017 Jul;47(7):1171-1180. doi: 10.1002/eji.201746939. Epub 2017 May 23.

8.

Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation.

Starick L, Riano F, Karunakaran MM, Kunzmann V, Li J, Kreiss M, Amslinger S, Scotet E, Olive D, De Libero G, Herrmann T.

Eur J Immunol. 2017 Jun;47(6):982-992. doi: 10.1002/eji.201646818. Epub 2017 Apr 27.

9.

The autophagy machinery restrains iNKT cell activation through CD1D1 internalization.

Keller CW, Loi M, Ewert S, Quast I, Theiler R, Gannagé M, Münz C, De Libero G, Freigang S, Lünemann JD.

Autophagy. 2017 Jun 3;13(6):1025-1036. doi: 10.1080/15548627.2017.1297907. Epub 2017 Mar 15.

10.

Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis.

Larrouy-Maumus G, Layre E, Clark S, Prandi J, Rayner E, Lepore M, de Libero G, Williams A, Puzo G, Gilleron M.

Vaccine. 2017 Mar 7;35(10):1395-1402. doi: 10.1016/j.vaccine.2017.01.079. Epub 2017 Feb 9.

PMID:
28190740
11.

From Immunologically Archaic to Neoteric Glycovaccines.

Cavallari M, De Libero G.

Vaccines (Basel). 2017 Jan 27;5(1). pii: E4. doi: 10.3390/vaccines5010004. Review.

12.

Microchip-based ultrafast serodiagnostic assay for tuberculosis.

Mani V, Paleja B, Larbi K, Kumar P, Tay JA, Siew JY, Inci F, Wang S, Chee C, Wang YT, Demirci U, De Libero G, Singhal A.

Sci Rep. 2016 Oct 24;6:35845. doi: 10.1038/srep35845.

13.

Lysosomal Lipases PLRP2 and LPLA2 Process Mycobacterial Multi-acylated Lipids and Generate T Cell Stimulatory Antigens.

Gilleron M, Lepore M, Layre E, Cala-De Paepe D, Mebarek N, Shayman JA, Canaan S, Mori L, Carrière F, Puzo G, De Libero G.

Cell Chem Biol. 2016 Sep 22;23(9):1147-1156. doi: 10.1016/j.chembiol.2016.07.021.

14.

Selection of phage-displayed human antibody fragments specific for CD1b presenting the Mycobacterium tuberculosis glycolipid Ac2SGL.

Camacho F, Sarmiento ME, Reyes F, Kim L, Huggett J, Lepore M, Otero O, Gilleron M, Puzo G, Norazmi MN, Rook G, Mori L, De Libero G, Acosta A.

Int J Mycobacteriol. 2016 Jun;5(2):120-7. doi: 10.1016/j.ijmyco.2015.12.002. Epub 2016 Feb 17.

15.

Broad-Spectrum Antimicrobial Star Polycarbonates Functionalized with Mannose for Targeting Bacteria Residing inside Immune Cells.

Yang C, Krishnamurthy S, Liu J, Liu S, Lu X, Coady DJ, Cheng W, De Libero G, Singhal A, Hedrick JL, Yang YY.

Adv Healthc Mater. 2016 Jun;5(11):1272-81. doi: 10.1002/adhm.201600070. Epub 2016 Mar 29.

PMID:
27028263
16.

The Immunology of CD1- and MR1-Restricted T Cells.

Mori L, Lepore M, De Libero G.

Annu Rev Immunol. 2016 May 20;34:479-510. doi: 10.1146/annurev-immunol-032414-112008. Epub 2016 Feb 25. Review.

PMID:
26927205
17.

Hemopoietic cell kinase (Hck) and p21-activated kinase 2 (PAK2) are involved in the down-regulation of CD1a lipid antigen presentation by HIV-1 Nef in dendritic cells.

Shinya E, Shimizu M, Owaki A, Paoletti S, Mori L, De Libero G, Takahashi H.

Virology. 2016 Jan;487:285-95. doi: 10.1016/j.virol.2015.10.023. Epub 2015 Nov 14.

18.

Globotriaosylceramide inhibits iNKT-cell activation in a CD1d-dependent manner.

Pereira CS, Sa-Miranda C, De Libero G, Mori L, Macedo MF.

Eur J Immunol. 2016 Jan;46(1):147-53. doi: 10.1002/eji.201545725. Epub 2015 Oct 20.

19.

Automated Identification of Core Regulatory Genes in Human Gene Regulatory Networks.

Narang V, Ramli MA, Singhal A, Kumar P, de Libero G, Poidinger M, Monterola C.

PLoS Comput Biol. 2015 Sep 22;11(9):e1004504. doi: 10.1371/journal.pcbi.1004504. eCollection 2015.

20.

Targeting leukemia by CD1c-restricted T cells specific for a novel lipid antigen.

Lepore M, de Lalla C, Mori L, Dellabona P, De Libero G, Casorati G.

Oncoimmunology. 2014 Dec 3;4(3):e970463. eCollection 2015 Mar.

21.

Phosphoantigen Presentation to TCR γδ Cells, a Conundrum Getting Less Gray Zones.

De Libero G, Lau SY, Mori L.

Front Immunol. 2015 Jan 15;5:679. doi: 10.3389/fimmu.2014.00679. eCollection 2014. Review.

22.

Metformin as adjunct antituberculosis therapy.

Singhal A, Jie L, Kumar P, Hong GS, Leow MK, Paleja B, Tsenova L, Kurepina N, Chen J, Zolezzi F, Kreiswirth B, Poidinger M, Chee C, Kaplan G, Wang YT, De Libero G.

Sci Transl Med. 2014 Nov 19;6(263):263ra159. doi: 10.1126/scitranslmed.3009885.

23.

A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice.

Cavallari M, Stallforth P, Kalinichenko A, Rathwell DC, Gronewold TM, Adibekian A, Mori L, Landmann R, Seeberger PH, De Libero G.

Nat Chem Biol. 2014 Nov;10(11):950-6. doi: 10.1038/nchembio.1650. Epub 2014 Oct 5.

PMID:
25282505
24.

Nonclassical T cells and their antigens in tuberculosis.

De Libero G, Singhal A, Lepore M, Mori L.

Cold Spring Harb Perspect Med. 2014 Jul 24;4(9):a018473. doi: 10.1101/cshperspect.a018473. Review.

25.

Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.

Jo J, Tan AT, Ussher JE, Sandalova E, Tang XZ, Tan-Garcia A, To N, Hong M, Chia A, Gill US, Kennedy PT, Tan KC, Lee KH, De Libero G, Gehring AJ, Willberg CB, Klenerman P, Bertoletti A.

PLoS Pathog. 2014 Jun 26;10(6):e1004210. doi: 10.1371/journal.ppat.1004210. eCollection 2014 Jun.

26.

A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.

Lepore M, de Lalla C, Gundimeda SR, Gsellinger H, Consonni M, Garavaglia C, Sansano S, Piccolo F, Scelfo A, Häussinger D, Montagna D, Locatelli F, Bonini C, Bondanza A, Forcina A, Li Z, Ni G, Ciceri F, Jenö P, Xia C, Mori L, Dellabona P, Casorati G, De Libero G.

J Exp Med. 2014 Jun 30;211(7):1363-77. doi: 10.1084/jem.20140410. Epub 2014 Jun 16.

27.

The T-Cell Response to Lipid Antigens of Mycobacterium tuberculosis.

De Libero G, Mori L.

Front Immunol. 2014 May 22;5:219. doi: 10.3389/fimmu.2014.00219. eCollection 2014. Review.

28.

Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care.

Mani V, Wang S, Inci F, De Libero G, Singhal A, Demirci U.

Adv Drug Deliv Rev. 2014 Nov 30;78:105-17. doi: 10.1016/j.addr.2014.05.015. Epub 2014 Jun 2. Review.

29.

Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire.

Lepore M, Kalinichenko A, Colone A, Paleja B, Singhal A, Tschumi A, Lee B, Poidinger M, Zolezzi F, Quagliata L, Sander P, Newell E, Bertoletti A, Terracciano L, De Libero G, Mori L.

Nat Commun. 2014 May 15;5:3866. doi: 10.1038/ncomms4866. Erratum in: Nat Commun. 2014;5:4493. Kalinicenko, Artem [corrected to Kalinichenko, Artem].

PMID:
24832684
30.

Synthesis and evaluation of immunostimulant plasmalogen lysophosphatidylethanolamine and analogues for natural killer T cells.

Ni G, Li Z, Liang K, Wu T, De Libero G, Xia C.

Bioorg Med Chem. 2014 Jun 1;22(11):2966-73. doi: 10.1016/j.bmc.2014.04.012. Epub 2014 Apr 13.

PMID:
24767817
31.

Professional differences in antigen presentation to iNKT cells.

De Libero G, Mori L.

Immunity. 2014 Jan 16;40(1):5-7. doi: 10.1016/j.immuni.2013.12.008.

32.

T cell recognition of non-peptidic antigens in infectious diseases.

Singhal A, Mori L, De Libero G.

Indian J Med Res. 2013 Nov;138(5):620-31. Review.

33.

Simplified deoxypropionate acyl chains for Mycobacterium tuberculosis sulfoglycolipid analogues: chain length is essential for high antigenicity.

Gau B, Lemétais A, Lepore M, Garcia-Alles LF, Bourdreux Y, Mori L, Gilleron M, De Libero G, Puzo G, Beau JM, Prandi J.

Chembiochem. 2013 Dec 16;14(18):2413-7. doi: 10.1002/cbic.201300482. Epub 2013 Oct 31. No abstract available.

PMID:
24174158
34.

Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells.

Vavassori S, Kumar A, Wan GS, Ramanjaneyulu GS, Cavallari M, El Daker S, Beddoe T, Theodossis A, Williams NK, Gostick E, Price DA, Soudamini DU, Voon KK, Olivo M, Rossjohn J, Mori L, De Libero G.

Nat Immunol. 2013 Sep;14(9):908-16. doi: 10.1038/ni.2665. Epub 2013 Jul 21.

PMID:
23872678
35.

IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells.

Tang XZ, Jo J, Tan AT, Sandalova E, Chia A, Tan KC, Lee KH, Gehring AJ, De Libero G, Bertoletti A.

J Immunol. 2013 Apr 1;190(7):3142-52. doi: 10.4049/jimmunol.1203218. Epub 2013 Feb 27.

36.

Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics.

Wang S, Inci F, De Libero G, Singhal A, Demirci U.

Biotechnol Adv. 2013 Jul-Aug;31(4):438-49. doi: 10.1016/j.biotechadv.2013.01.006. Epub 2013 Jan 26. Review.

37.

Deciphering the role of CD1e protein in mycobacterial phosphatidyl-myo-inositol mannosides (PIM) processing for presentation by CD1b to T lymphocytes.

Cala-De Paepe D, Layre E, Giacometti G, Garcia-Alles LF, Mori L, Hanau D, de Libero G, de la Salle H, Puzo G, Gilleron M.

J Biol Chem. 2012 Sep 7;287(37):31494-502. doi: 10.1074/jbc.M112.386300. Epub 2012 Jul 10.

38.

T cells specific for lipid antigens.

Mori L, De Libero G.

Immunol Res. 2012 Sep;53(1-3):191-9. doi: 10.1007/s12026-012-8294-6. Review.

PMID:
22427014
39.

Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus.

Facciotti F, Ramanjaneyulu GS, Lepore M, Sansano S, Cavallari M, Kistowska M, Forss-Petter S, Ni G, Colone A, Singhal A, Berger J, Xia C, Mori L, De Libero G.

Nat Immunol. 2012 Mar 18;13(5):474-80. doi: 10.1038/ni.2245.

PMID:
22426352
40.

Novel insights into lipid antigen presentation.

De Libero G, Mori L.

Trends Immunol. 2012 Mar;33(3):103-11. doi: 10.1016/j.it.2012.01.005. Epub 2012 Feb 16. Review.

PMID:
22342205
41.

Structural reorganization of the antigen-binding groove of human CD1b for presentation of mycobacterial sulfoglycolipids.

Garcia-Alles LF, Collmann A, Versluis C, Lindner B, Guiard J, Maveyraud L, Huc E, Im JS, Sansano S, Brando T, Julien S, Prandi J, Gilleron M, Porcelli SA, de la Salle H, Heck AJ, Mori L, Puzo G, Mourey L, De Libero G.

Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17755-60. doi: 10.1073/pnas.1110118108. Epub 2011 Oct 17.

42.

Fine tuning by human CD1e of lipid-specific immune responses.

Facciotti F, Cavallari M, Angénieux C, Garcia-Alles LF, Signorino-Gelo F, Angman L, Gilleron M, Prandi J, Puzo G, Panza L, Xia C, Wang PG, Dellabona P, Casorati G, Porcelli SA, de la Salle H, Mori L, De Libero G.

Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14228-33. doi: 10.1073/pnas.1108809108. Epub 2011 Aug 15.

43.

IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation.

Kyriakakis E, Cavallari M, Pfaff D, Fabbro D, Mestan J, Philippova M, De Libero G, Erne P, Resink TJ.

J Leukoc Biol. 2011 Nov;90(5):929-39. doi: 10.1189/jlb.0211097. Epub 2011 Aug 1.

PMID:
21807744
44.

Crystal structure of human CD1e reveals a groove suited for lipid-exchange processes.

Garcia-Alles LF, Giacometti G, Versluis C, Maveyraud L, de Paepe D, Guiard J, Tranier S, Gilleron M, Prandi J, Hanau D, Heck AJ, Mori L, De Libero G, Puzo G, Mourey L, de la Salle H.

Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13230-5. doi: 10.1073/pnas.1105627108. Epub 2011 Jul 25.

45.

The HOX gene network in hepatocellular carcinoma.

Cillo C, Schiavo G, Cantile M, Bihl MP, Sorrentino P, Carafa V, D' Armiento M, Roncalli M, Sansano S, Vecchione R, Tornillo L, Mori L, De Libero G, Zucman-Rossi J, Terracciano L.

Int J Cancer. 2011 Dec 1;129(11):2577-87. doi: 10.1002/ijc.25941. Epub 2011 May 30.

46.

High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells.

de Lalla C, Lepore M, Piccolo FM, Rinaldi A, Scelfo A, Garavaglia C, Mori L, De Libero G, Dellabona P, Casorati G.

Eur J Immunol. 2011 Mar;41(3):602-10. doi: 10.1002/eji.201041211. Epub 2011 Jan 18.

47.

The easy virtue of CD1c.

De Libero G, Mori L.

Immunity. 2010 Dec 14;33(6):831-3. doi: 10.1016/j.immuni.2010.12.001. No abstract available.

48.

Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis.

Kyriakakis E, Cavallari M, Andert J, Philippova M, Koella C, Bochkov V, Erne P, Wilson SB, Mori L, Biedermann BC, Resink TJ, De Libero G.

Eur J Immunol. 2010 Nov;40(11):3268-79. doi: 10.1002/eji.201040619. Epub 2010 Oct 27.

49.

Early recycling compartment trafficking of CD1a is essential for its intersection and presentation of lipid antigens.

Cernadas M, Cavallari M, Watts G, Mori L, De Libero G, Brenner MB.

J Immunol. 2010 Feb 1;184(3):1235-41. doi: 10.4049/jimmunol.0804140. Epub 2009 Dec 21.

50.

How the immune system detects lipid antigens.

De Libero G, Mori L.

Prog Lipid Res. 2010 Apr;49(2):120-7. doi: 10.1016/j.plipres.2009.10.002. Epub 2009 Oct 24. Review.

PMID:
19857519

Supplemental Content

Loading ...
Support Center